SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-18-004674
Filing Date
2018-05-10
Accepted
2018-05-10 16:59:10
Documents
58
Period of Report
2018-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q kala-20180331x10q.htm 10-Q 1547147
2 EX-31.1 kala-20180331ex311adc207.htm EX-31.1 21323
3 EX-31.2 kala-20180331ex31283c992.htm EX-31.2 21321
4 EX-32.1 kala-20180331ex321e25e5a.htm EX-32.1 8998
5 EX-32.2 kala-20180331ex32224523f.htm EX-32.2 9409
  Complete submission text file 0001558370-18-004674.txt   5014504

Data Files

Seq Description Document Type Size
6 EX-101.INS kala-20180331.xml EX-101.INS 948130
7 EX-101.SCH kala-20180331.xsd EX-101.SCH 32896
8 EX-101.CAL kala-20180331_cal.xml EX-101.CAL 35604
9 EX-101.DEF kala-20180331_def.xml EX-101.DEF 110731
10 EX-101.LAB kala-20180331_lab.xml EX-101.LAB 332266
11 EX-101.PRE kala-20180331_pre.xml EX-101.PRE 236385
Mailing Address 100 BEAVER STREET SUITE 201 WALTHAM MA 02453
Business Address 100 BEAVER STREET SUITE 201 WALTHAM MA 02453 781-996-5252
Kala Pharmaceuticals, Inc. (Filer) CIK: 0001479419 (see all company filings)

IRS No.: 270604595 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38150 | Film No.: 18823795
SIC: 2834 Pharmaceutical Preparations